Surgical Robots Market Outlook:
Surgical Robots Market size was valued at USD 7 billion in 2024 and is projected to reach USD 28.2 billion by the end of 2037, rising at a CAGR of 16.9% during the forecast timeline, 2025 to 2037. In 2025, the industry size of the surgical robot is estimated at USD 8.5 billion.
The patient pool for surgical robots is expanding rapidly, driven by the increasing demand for minimally invasive procedures, especially in advanced economies with aging populations. According to the U.S. National Institutes of Health (NIH), conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders have resulted in a rising number of surgical interventions, many of which are now being performed with robotic assistance. For example, data from the National Health Service (NHS) in the UK indicates that the demand for robotic surgeries has surged by over 29% in the past five years alone, particularly in orthopaedics and urology. These increasing patient needs are expanding the target market for robotic surgery providers, who must adjust to accommodate both the growing number of procedures and the rising complexity of surgical techniques.
In terms of supply dynamics, the globalized trade and assembly of surgical robots require complex supply chains for key components. The production process needs raw materials such as high-quality metals for operating robotic arms, optics, and AI automation software. The assembly is probably undertaken in regions of high-tech manufacturing capability. Moreover, trade in surgical robotics will require sustained investment in research, development, and deployment (RDD) for continued reach into surgical robotics.
Surgical Robots Market - Growth Drivers and Challenges
Growth Drivers
- Government spending on healthcare technology: Funding from the government is a crucial factor in the acceptance and growth of surgical robots. For instance, in the U.S., Medicare.gov reported government reimbursable expenditures for surgical robot products of approximately USD 1.2 billion in 2023. Further, there are still major governmental and EU-funded programs in Europe, such as EU Horizon 2020 and other initiatives that are still redistributing investments towards robotic-assisted surgery. Investments are projected to continue increasing since countries are focused on improving the capacity of modern healthcare infrastructures.
- Increasing patient pool & disease prevalence: As a result, the growing incidence of disease ahead of surgical intervention has made surgical robots increasingly relevant. For instance, in Germany, the incidence of diseases treated with robotic-assisted surgery will rise by 14% by the end of 2025. This will fuel additional demands for robotic surgical systems. The growing, aging population in North America and Europe continues to drive the need for advanced surgical techniques.
- Healthcare quality improvement & cost-effectiveness: Surgical robots are becoming increasingly recognized as a mechanism for improving quality in health care. A report from the Agency for Healthcare Research and Quality (AHRQ), published in 2022, described the introduction of robotic-assisted surgery (RAS), which was found to decrease the length of stay in early treatment of patients diagnosed with prostate cancer by 19%. The results also support an increased emphasis on cost-efficient interventions that improve outcomes for patients.
Historical Patient Growth (2010-2020) & Future Revenue Opportunities for Surgical Robots Manufacturers
The rise of surgical robots in the global healthcare landscape has been influenced substantially by the increasing adoption of minimally invasive procedures and robot-assisted surgeries. There was significant growth in the number of patients undergoing robotic-assisted surgeries between 2010 and 2020. The historical pool of patients in countries such as the USA and Germany will see steady growth due to government backing and modernization of public and private healthcare systems. The increase in robotic surgeries suggests more than the actual demand for healthcare. Regarding countries such as China and India, we witnessed slow adoption of robotic technologies in the beginning.
|
Region |
2010 (Million Patients) |
2020 (Million Patients) |
Growth % |
|
USA |
0.6 |
2.3 |
500% |
|
Germany |
0.5 |
1.5 |
600% |
|
France |
0.6 |
0.6 |
400% |
|
Spain |
0.17 |
0.7 |
400% |
|
Australia |
0.2 |
0.8 |
500% |
|
Japan |
0.3 |
0.8 |
700% |
|
India |
0.04 |
0.5 |
800% |
|
China |
0.06 |
0.6 |
600% |
Manufacturer Strategies & Revenue Potential in the Surgical Robots Market
Leading surgical robot manufacturers on the market have established the market landscape through product innovations, partnerships, and regional development. Intuitive Surgical entered 2023 with new models of the da Vinci Surgical System and increased its market share by 11% growth. Similarly, Medtronic capitalized on this focus with its Hugo system, launching AI-driven functionalities that improved usability. These manufacturers utilized a strategy of innovations reflective of industry trends of adding AI, improving surgical precision, and developing recovery times. Manufacturers have used partnerships and market development to increase the sales market size. The table below employs revenue growth strategies related to manufacturers' market position.
|
Company |
Strategy |
Revenue Impact (USD) |
Market Share Growth (2023) |
Key Innovations |
|
Intuitive Surgical |
Product innovation and system upgrades (da Vinci) |
+500 million |
+11% |
AI-assisted robotic systems |
|
Medtronic |
Integration of AI for improved precision |
+240 million |
+9% |
AI-driven Hugo™ system enhancements |
|
Stryker |
Expansion into emerging markets |
+140 million |
+11% |
Smart robotic navigation systems |
|
Zimmer Biomet |
Strategic partnerships in Asia-Pacific |
+200 million |
+8% |
Next-gen robotic knee and hip surgeries |
Challenges
- High up-front & maintenance costs: A single surgical robot may range in cost from USD 1 - 2 million. Governments and hospitals find it difficult to justify ROI. Robotic procedures are reimbursed under the same DRGs or CPT codes as laparoscopic surgery, but they end up costing significantly more.
- Payer skepticism & limited medicaid coverage: Medicaid pays around 65–77% of Medicare rates. This leaves many people without access to procedures. Medicaid patients are taking part in a high-robot area. Whereas, patients still have the lowest uptake of the procedure, likely due in part to cost restrictions.
Surgical Robots Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
16.9% |
|
Base Year Market Size (2024) |
USD 7 billion |
|
Forecast Year Market Size (2037) |
USD 28.2 billion |
|
Regional Scope |
|
Surgical Robots Market Segmentation:
End User Segment Analysis
Based on the end user, the hospitals segment is predicted to capture the largest share at 41% in the surgical robot market over the assessed period. Hospitals are leading the way in adopting new technologies due to their larger budgets and better integration capabilities. Hospitals are outpacing ambulatory services and clinics in terms of adoption rates. Additionally, the recent push for "best-practice tariffs" in NHS hospitals is encouraging even more use of robotic systems.
Application Segment Analysis
In terms of application, the general surgery segment is anticipated to hold the highest revenue proportion of 30% in the surgical robot market throughout the discussed timeline. General surgery is at the forefront of medical procedures. This is due to its wide range of applications, including cholecystectomy, hernia repairs, and colorectal surgeries. Various robotic platforms, such as da Vinci Surgical System, are customizable and versatile and considered ideal for general surgery. These state-of-the-art products offer 3D visualization and precise instrument control.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegment |
|
Type |
|
|
Component |
|
|
Application |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Surgical Robots Market - Regional Analysis
North America Market Insights
North America is expected to dominate the global surgical robots’ market with a share of 47% by the end of 2037. Strong contributors include rising demand for minimally invasive procedures, government funding, and payer system endorsement. The U.S. has a well-established reimbursement structure that supports an infrastructure for wider adoption, standard DRGs, and CPT codes for robotic procedures. Canada's provincial healthcare systems have pushed to incorporate robots into public hospitals. Furthermore, growth is driven by rising surgical volumes from aging patient populations and incidences of chronic disease, and trending to a preferred methodology of precision techniques. In Canada, a regulatory support environment and regional utilization growth are encouraging growth across regions. Public sector funding for hospital infrastructure through provincial budgets for robotics expansion has translated into deployment at over 200 centers.
Federal budget structures support surgical robotic development. HHS and NIH provide grants for research and technology, although CMS reimbursement provided through Medicare improves access to coverage. Medicare does not charge an additional payment for robotic assistance under the DRG methodology. CDC and AHRQ constitute another budget line that also finances surgical robotic development indirectly through workforce development. FDA approval pathways are still in place and expanding. Major trends include expansion of Medicare-approved robotic procedures and reimbursement for robotic procedures by private insurers predicted that the U.S. surgical robotics market is expected to grow.
APAC Market Insights
Asia Pacific is poised to register the highest pace of growth in the global surgical robots market by the end of 2037. The growth is driven by rising healthcare investments, aging populations, and preference for minimally invasive surgeries. Japan and China will dominate the regional market. Japan's allocations show that the national healthcare plan allocates 13% to surgical robotics in 2024. Japan's minimum health budget increased from two years ago was USD 2 billion. China's allocation in recent years has shown a 14% growth in spending on robotic surgery systems by the National Medical Products Administration (NMPA). This allowed surgical robots to perform more than 1.2 million surgical procedures in 2023.
In India, government spending increased 17% from 2015 to 2023. Malaysia also saw patient numbers double from 2013 to 2023. South Korea has continued to develop its robotic surgery industry while still subsidizing robotic surgery. Market expansion is also credited in this region to several partnerships between multinational robotic system manufacturers and local hospitals. By 2037, Japan and China will be estimated to combine for over 54% of regional market revenue.
Europe Market Insights
The Europe surgical robots market is estimated to garner a notable industry value from 2025 to 2037. The growth can be attributed to the high healthcare spending and supportive regulation. The UK market is estimated to be £1.1 billion in 2024. An increase in funding is indicative of a surge in demand for the da Vinci Robot, with 43% of all prostatectomies now carried out as robotic-assisted. The ABPI has predicted that 11% annual growth in robotic surgery will be driven by AI uptake. Germany is the top country in Europe for spending on surgical robots. In France, the agencies reporting has stated that 6% of the healthcare budget was available for surgical robots in 2023. The emerging "My Health 2025" plan implicitly prioritizes robotic surgery.
Government Investment & Development in Surgical Robots Market
|
Region |
Government Investment (Est.) |
Key Development Programs |
|
Italy |
€150–201 million |
National Recovery and Resilience Plan (NRRP) – EU-funded tech modernization in healthcare |
|
Spain |
€100–152 million |
Spain Digital Health Strategy, PERTE Salud de Vanguardia program |
|
Russia |
(€131–160M) |
National Technology Initiative (NTI), Healthcare 2030 Agenda |
|
Nordic Region (Sweden, Finland, Norway, Denmark, Iceland) |
€250–301 million (cumulative) |
Nordic HealthTech funding programs, national AI strategies (Sweden, Finland) |
|
Rest of Europe (e.g., Poland, Czech Republic, Hungary, etc.) |
€200–252 million (EU-supported) |
EU Horizon Europe, Digital Europe Programme, National Resilience Plans |
Key Surgical Robots Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The surgical robotics industry is quite consolidated. They operate on a razor-and-blade revenue model, relying on instruments and services. Stryker is at the forefront of orthopedic surgery with its Mako platform. Accuray and Zimmer Biomet are carving out their niches in radiosurgery and spine applications. CMR Surgical, Asensus, and Renishaw are shaking things up with innovative modular designs, haptic feedback.
|
Company |
Country |
Est. 2024 Market Share |
|
Intuitive Surgical |
USA |
~42% |
|
Stryker Corporation (USA) |
USA |
~20% |
|
Medtronic plc (Ireland/USA) |
USA |
~8.6% |
|
Johnson & Johnson (USA) |
USA |
~4.4% |
|
Accuray Inc. (USA) |
USA |
~4.2% |
|
Zimmer Biomet (USA) |
USA |
~xx% |
|
CMR Surgical |
UK |
~xx% |
|
Asensus Surgical |
USA |
~xx% |
|
Renishaw plc |
UK |
~xx% |
|
Globus Medical |
USA |
~xx% |
|
Brainlab |
Germany |
~xx% |
|
Corindus Vascular Robotics (USA) |
USA |
~xx% |
|
Medrobotics (USA) |
USA |
~xx% |
|
Distalmotion |
Switzerland) |
~xx% |
|
Think Surgical |
USA |
~xx% |
|
Medicaroid |
Japan |
~xx% |
|
Kawasaki Heavy Industries |
Japan |
~xx% |
|
Doosan Robotics |
South Korea) |
~xx% |
|
Meril Life Sciences |
India |
~xx% |
|
Zeta Surgical |
USA |
~xx% |
Below are the areas covered for each company in the surgical robots market:
Recent Developments
- In March 2024, Intuitive Surgical installed 110 da Vinci 5 systems. This increased the total installations to 378 for the quarter. Revenue hit USD 2 billion. This marks a 16% increase year-over-year. This growth is partly fueled by the rising adoption of the da Vinci 5 system.
- In March 2024, CMR Surgical announced the launch of Versius Pediatric. The NHS has just completed its first pediatric surgery using Versius in the UK. They've also celebrated their 19,000th overall procedure. This highlights the growing acceptance of this modular system within the NHS.
- Report ID: 3875
- Published Date: Jul 02, 2025
- Report Format: PDF, PPT
Have specific data needs or budget constraints?
Reach out to us for a customized quote or to learn more about our special pricing
for startups and universities
Frequently Asked Questions (FAQ)
Surgical Robots Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
